All products sold by Peak Peptides are intended strictly for laboratory research and development purposes only. They are not for human consumption, medical, or veterinary use. None of the statements on this site have been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. Dismiss
IGF-1 LR3 (Long Arg3 Insulin-Like Growth Factor-1) is a synthetic, bioengineered analog of native human IGF-1, modified to enhance biological stability and receptor binding affinity in controlled research environments. Structurally, IGF-1 LR3 differs from endogenous IGF-1 by a substitution of arginine for glutamic acid at position 3 and the addition of a 13-amino-acid extension on the N-terminus, resulting in increased half-life and reduced binding to IGF-binding proteins (IGFBPs). These modifications allow for prolonged activity and greater availability for receptor interaction, making IGF-1 LR3 a valuable peptide for studying cellular growth, differentiation, and repair mechanisms.
In scientific research, IGF-1 LR3 has been investigated for its ability to activate the IGF-1 receptor (IGF-1R) and downstream PI3K/Akt and MAPK signaling pathways, which are central to protein synthesis, glucose metabolism, and cell survival. Its anabolic-like actions have been explored in models evaluating skeletal muscle hypertrophy, tissue regeneration, neural development, and metabolic function. Studies also indicate potential roles in insulin sensitivity, myocyte differentiation, and connective-tissue remodeling, positioning IGF-1 LR3 as a leading compound for research on cellular longevity and anabolic regulation.
IGF-1 LR3’s extended duration of action—lasting up to 20–30 hours in some research models—has made it especially useful for evaluating growth-factor kinetics, receptor desensitization, and metabolic feedback loops. Its broad relevance extends across endocrine physiology, muscle repair, and regenerative biology, providing scientists with a highly stable platform for examining growth-factor signaling dynamics.
Key Research Benefits
Studied for its activation of IGF-1 receptor pathways and PI3K/Akt signaling
Supports research on cell growth, differentiation, and metabolic regulation
May aid in understanding muscle repair, tissue regeneration, and connective-tissue adaptation
Explored for its role in insulin sensitivity, protein synthesis, and cellular energy balance
Demonstrates extended half-life and stability, allowing for prolonged receptor engagement in research models
⚠️ Disclaimer
All products, including IGF-1 LR3, are sold for laboratory and research purposes only. Not for human consumption, medical, or veterinary use.
Reviews
There are no reviews yet.